One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.493.493
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Sarah Cannon, Verastem (United States), Ghent University Hospital, Columbia University Irving Medical Center, Ospedale Niguarda Ca' Granda, Institut Bergonié, Vall d'Hebron Hospital Universitari, Petz Aladár Megyei Oktató Kórház, St Vincent's Hospital, University of Virginia, Dana-Farber Cancer Institute, Hôpital Avicenne, Semmelweis University, Flinders Medical Centre, University of Debrecen, Hospital Clínic de Barcelona, Hackensack Meridian Health, Washington University in St. Louis, Florida Cancer Specialists & Research Institute, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Medical University of Vienna, University Hospital UlmResults from the Phase 3 DUOTM Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
